SHIONOGI
Shionogi & Co., Ltd. is a Japan-based pharmaceutical company. It is engaged in the research, development, purchase, manufacture and sale of pharmaceuticals, as well as pharmaceutical-related businesses. The Company mainly provides vitamin preparations, analgesic antipyretics, cold and sinus medicine, digestive medicine, dermatologic preparations, antiphlogistic analgetics, antihypercholesterolemic agents, test paper for glucose in urine and artificial teeth-related products.
SHIONOGI
Social Links:
Industry:
Biotechnology Medical Pharmaceutical
Founded:
1878-03-17
Address:
Osaka-shi, Osaka, Japan
Country:
Japan
Website Url:
http://www.shionogi.com
Total Employee:
10001+
Status:
Active
Contact:
+81662022161
Total Funding:
7.6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Domain Not Resolving Apache Global Site Tag
Similar Organizations
Aspen Pharmacare
Aspen Pharmacare is a global supplier of branded and generic pharmaceutical products.
Bayer
Bayer is a life science company that specializes in the areas of health care and agriculture.
Becton Dickinson India
BD is a global medical technology company that is advancing the world of health by improving medical discovery.
Boehringer Ingelheim
Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies.
British Army
British Army is the principal land warfare force of the United Kingdom.
Dongwha Pharm
Dongwha Pharm offers drugs such as antipyretics, analgesics, and antibiotics for cardiovascular, and alimentary ailments.
Guangyuyuan
GuangYuYuan Chinese Herbal Medicine Co., Ltd. develops and manufactures Chinese raw material medicines as well as advertising services.
Hisamitsu Pharmaceutical
Hisamitsu Pharmaceutical is a medical product company that offers a pain relief patch.
KNMP
KNMP is the Royal Dutch Society for the Promotion of Pharmacy is the umbrella professional and branch organization of pharmacists.
Mallinckrodt
Their evolution as a company starts now, and they are poised for an exciting future. Their core strengths provide the impetus for future
Meiji Holdings
Meiji Holdings provides disaster relief through donations and contributions to people/businesses in need.
Novo Nordisk
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care.
Teva Pharmaceutical Industries
Teva Pharmaceutical Industries is a pharmaceutical company specializing in the development, production and marketing of generic.
TTY Biopharm
TTY Biopharm is to improve the quality of human life with scientific innovation.
University of California, San Francisco
Director of the Lab for Advanced Cytometry (LAC) and the Sony Biotechnology Center at UCSF in the Department of Laboratory Medicine
Zhongyuan Union Cell & Gene Eng
Zhongyuan Union Cell & Gene Eng is principally engaged in the detection and storage of stem cell sources.
Walgreens
Walgreens is a pharmacy, health, and wellness service center that offers trained infusion nurses and pharmacists to treat patients.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-05-26 | Tetra Therapeutics | Tetra Therapeutics acquired by Shionogi | N/A |
| 2008-09-02 | Shionogi Pharma Inc. | Shionogi Pharma Inc. acquired by Shionogi | 1.4 B USD |
Investors List
CARB-X
CARB-X investment in Grant - Shionogi
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-05-26 | Akili Interactive Labs | Shionogi investment in Series D - Akili Interactive Labs | 110 M USD |
| 2019-05-07 | Aillis | Shionogi investment in Venture Round - Aillis | 1.25 B JPY |
| 2019-01-15 | Vast Therapeutics | Shionogi investment in Series A - Vast Therapeutics | 15 M USD |
| 2018-10-05 | FunPep | Shionogi investment in Venture Round - FunPep | 460 M JPY |
| 2018-04-18 | PeptiStar | Shionogi investment in Corporate Round - PeptiStar | 20 B JPY |
| 2015-10-27 | FunPep | Shionogi investment in Venture Round - FunPep | 50 M JPY |
| 2014-12-15 | StemRIM | Shionogi investment in Corporate Round - StemRIM | 800 M JPY |
| 2004-01-16 | Peninsula Pharmaceuticals | Shionogi investment in Series C - Peninsula Pharmaceuticals | 57.9 M USD |
Official Site Inspections
http://www.shionogi.com Semrush global rank: 245.61 K Semrush visits lastest month: 284.92 K
- Host name: 238.41.180.107.host.secureserver.net
- IP address: 107.180.41.238
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Shionogi"
Company Profile | About Shionogi | Shionogi & Co., Ltd.
Mar 31, 2024 Corporate Name: Shionogi & Co., Ltd. Chief Executives: Isao Teshirogi, Ph.D., Representative Director, President and CEO: Established: March 17, 1878: IncorporatedSee details»
Corporate Governance System - Shionogi & Co., Ltd.
To ensure directors and each organization in the Company conduct their duties in a legally compliant and appropriate manner, the Company has established systems to enable corporate …See details»
Org Chart Shionogi - The Official Board
The organizational chart of Shionogi displays its 36 main executives including Isao Teshirogi, Akira Kato and John Keller. Toggle navigation The Official Board. Search. Search. Search by …See details»
Shionogi - Wikipedia
Shionogi & Company, Limited (塩野義製薬株式会社, Shionogi Seiyaku Kabushiki Kaisha) is a Japanese pharmaceutical company best known for developing Crestor. Medical supply and brand name also uses katakana (シオノギ). Shionogi has business roots that date back to 1878, and was incorporated in …See details»
Shionogi - The Org
Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 140-year-old global pharmaceutical company with headquarters in Osaka, Japan. In the U.S., Shionogi Inc. leverages their science-based heritage to develop and …See details»
Shionogi Inc. (U.S.) | LinkedIn
Shionogi Inc. (U.S.) | 18,511 followers on LinkedIn. Our mission is to supply the best possible medicines to protect the health and well-being of the patients we serve | Since 1878, we have been ...See details»
Shionogi - Overview, News & Similar companies | ZoomInfo.com
Who is Shionogi. Shionogi is enhancing our strengths as a drug discovery-based pharmaceutical company to create innovative products and services and to deliver valu e in collaboration with …See details»
Bob Marino - VP Of Business Development At Shionogi Inc. at
Bob Marino has extensive experience in business development and leadership roles. Bob is currently the VP of Business Development at Shionogi Inc., a position they have held since …See details»
Shionogi - Crunchbase Company Profile & Funding
Shionogi developed a therapy for vulvar and vaginal atrophy, a condition occurring post-menopause. Show More . Lists Featuring This Company. Edit Lists Featuring This Company Section. Investors Active in California (Top 10K) …See details»
About Shionogi | Shionogi & Co., Ltd.
Shionogi is enhancing our strengths as a drug discovery-based pharmaceutical company to create innovative products and services and to deliver value in collaboration with a diverse array of partners. By delivering value to tackle …See details»
Shionogi Announces Strategic Re-Organization of U.S. Executive ...
Jun 1, 2022 FLORHAM PARK, N.J.--(BUSINESS WIRE)--Shionogi Inc., the United States subsidiary of Shionogi & Co., Ltd. based in New Jersey, has announced a strategic executive …See details»
Shionogi Expands Global Infectious Disease and Antimicrobial …
Jun 3, 2024 The Shionogi Qpex Lab will expand the existing R&D facility for Qpex Biopharma, Inc., a Shionogi Group Company (hereafter "Qpex"), with a new state-of-the-art discovery …See details»
Shionogi Provides Updates on Zatolmilast, an Investigational Drug …
OSAKA, Japan, July 18, 2024--Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter "Shionogi") today announced progress on the …See details»
Shionogi Inc. - A Discovery-Based Pharmaceutical Company
Shionogi Inc. is dedicated to advancing the greater good by developing, partnering, and commercializing medicine to treat serious unmet medical needs. Shionogi Inc. - A Discovery …See details»
Shionogi Announces New Phase 3 Data Showing Early Resolution …
OSAKA, Japan, February 09, 2024--Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter "Shionogi") announced the first peer …See details»
Shionogi Expands Global Infectious Disease and ... - Business Wire
Jun 3, 2024 The Shionogi Qpex Lab will expand the existing R&D facility for Qpex Biopharma, Inc., a Shionogi Group Company (hereafter “Qpex”), with a new state-of-the-art discovery …See details»
Philosophy | About Shionogi | Shionogi & Co., Ltd.
The purpose of the SHIONOGI Group's corporate activities is, as expressed in the opening of "The Company Policy of SHIONOGI", to "supply the best possible medicine to protect the …See details»
Shionogi & Co Ltd | Reuters
Mar 5, 2024 Japan's Shionogi & Co Ltd believes its COVID-19 pill will easily garner $2 billion in annual sales if it secures U.S. approval, which the company expects to receive in late 2024, its …See details»
News | Shionogi & Co., Ltd.
Shionogi & Co., Ltd. and Maze Therapeutics, Inc. Announce Exclusive Worldwide License Agreement for MZE001, a Novel Therapeutic Candidate for the Treatment of Pompe Disease …See details»